Related Experiment Videos
[Ehlers-Danlos syndrome IV: phenotype variation]
C H Engels1, P W van Dongen, G H Boers
1Afd. Antropogenetica, Academisch Ziekenhuis, Nijmegen.
Nederlands Tijdschrift Voor Geneeskunde
|February 8, 1997
Summary
Ehlers-Danlos syndrome (EDS) type IV, a severe collagen III deficiency, presents with variable symptoms. Collagen III deficiency analysis should be limited to suspected classical EDS IV cases to avoid misdiagnosis.
Area of Science:
- Genetics and Molecular Biology
- Connective Tissue Disorders
- Dermatology and Rheumatology
Background:
- Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders.
- EDS comprises 10 distinct types, each with unique clinical manifestations and genetic underpinnings.
- EDS type IV is characterized by a deficiency in collagen III, leading to severe complications.
Observation:
- Three female patients, aged 4, 20, and 29, were diagnosed with EDS type IV.
- Diagnosis was based on collagen III deficiency, presenting with hyperextensible skin, joints, and easy bruising.
- Symptomatic severity varied significantly among the affected individuals.
Findings:
- Collagen III deficiency is the hallmark of EDS type IV, a particularly severe form of the syndrome.
- Lethal complications, such as arterial rupture, are common in EDS type IV.
- Collagen III deficiency can occur in EDS patients without the classical severe EDS type IV phenotype.
Implications:
- The findings suggest that collagen III analysis should be reserved for patients with a high clinical suspicion of classical EDS type IV.
- This targeted approach may improve diagnostic accuracy and resource allocation in managing Ehlers-Danlos syndrome.
- Understanding the spectrum of collagen III deficiency in EDS is crucial for appropriate patient management and genetic counseling.